Although the mechanisms have not been explored in depth, JNK activation in glioma cells following chaetocin treatment led to a marked increase in PK activity and decrease of HK2 activity and expression [147], implying a role for the JNK pathway in restraining the glycolytic metabolism in glioma cells. Here, MAPK8 is linked to central nervous system cancer.